Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With WiFiMed
Date:2/12/2008

NEW YORK, Feb. 12 /PRNewswire/ -- On February 11, Greg Vacca, CEO of WiFiMed Holdings Company, Inc. (OTC Bulletin Board: WIFM) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company and its growth strategy, recent press releases, market opportunity, and upcoming milestones for which investors should watch.

To hear the interview, visit http://www.wallst.net and click "Interviews." Locate the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site or enter the company's ticker symbol in the Search Archive window.

Ask Greg Vacca a question, post a comment on his personal page, and join his financial social network today at http://www.mywallst.net.

About WiFiMed Holdings:

WiFiMed Holdings Company, Inc., through its wholly owned subsidiaries WiFiMed, Inc. and EncounterPRO Healthcare Resources, Inc., offers proprietary solutions enabling physicians and other healthcare providers to document the physician-patient encounter through continuously updated state-of-the-art technologies. WiFiMed Inc.'s proprietary product, Tablet MD(R) and EncounterPRO Healthcare Resources, Inc.'s proprietary product, EncounterPRO(R) EHR, were developed to assist physicians and health care providers manage patient workflow. Tablet MD(R) operates on a tablet PC and manages patient medical information, consultation notes, prescriptions, records, and charts through five proprietary technologies. The EncounterPRO(R) EHR gives physicians and staff the most flexible and sophisticated workflow engine available in an EHR. This premier software requires virtually no level of computer literacy and works off touch screens, Tablet PCs or a mouse as the primary means of data input. Both products have been designed to meet the Health Insurance Portability and Accountability Act (HIPAA) requirements and are designed to reduce medical errors, documentation time, overhead, and time spent filing insurance claims.

About WallSt.net

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The website is a leading provider of business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. owns http://www.mywallst.net, a financial social network for investors and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. WallStreet Direct also owns and operates WallStRadio, a business and finance podcast website. Financial Filings Corp. is expecting to receive two hundred eighty dollars from WiFiMed Holdings Company, Inc. for the dissemination of this press release. For a complete list of our advertisers and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WallSt.net Updates Investment Community Through All-New Interview With Transplant Creations
2. WallSt.net Announces Upcoming Interview With CEO of Avicena Group
3. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
4. WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard
5. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
6. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
7. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
8. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
9. Merrell Updates Performance Line with the Launch of OrthoLite Insoles
10. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
11. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 ... bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for people ... such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage ... up its marketing efforts with its product now available through Jet.com. , After ... public. The effervescent powdered drink is designed to quickly detox the body thereby avoiding ...
(Date:8/18/2017)... ... 2017 , ... 800response, the leading provider of dynamic call-to-action ... launch of a redesigned corporate website, 800response.com . , Key features ... an enhanced search directory for businesses and advertising agencies to use to ...
(Date:8/18/2017)... ... ... “Dangerous Inheritance”: a mystery about saving the family farm. “Dangerous Inheritance” ... where she was raised on a farm. As Diane wrote this story, she ... friendships and mantra of ‘neighbors helping neighbors’ have always been a large part of ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Beyond Our Imaginations: The Infinite God”: shows the ... Infinite God” is the creation of published author, Mark Lawrence, born in Michigan, the ... “The problem with becoming a greater man of God is that I have to ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
(Date:8/2/2017)... 2, 2017 Fenita J. Caldwell ... a Pinnacle Lifetime Professional in the Field of ... at Turing Pharmaceuticals, AG. Her skills and areas ... building.                ... years of experience as a highly successful sales ...
(Date:8/1/2017)... --  CerSci Therapeutics , a non-opioid drug development firm ... received notice from the National Institute on Drug Abuse ... it has been awarded a Direct-to-Phase II Small Business ... with an additional $1,000,000 to follow in 2018. These ... their lead non-opioid drug candidate CT-044 to the Food ...
Breaking Medicine Technology: